FDA to rule this week on Incyte's bid for wider use of Jakafi
May 22, 2019 at 13:03 PM EDT
The Wilmington biotech company is seeking to get its flagship drug Jakafi approved for a third use.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.